In fact, PAK4 has been associated with Parkinson’s disease (PD): patient substantia nigra exhibited reduced PAK4 expression [41], in vivo neuronal ablation of PAK4 increased aSYN aggregation and PAK4 gain-of-function reduced aggregation [42], although this impact was suggested to be indirect. This evidence concerns the gene PAK4 and Parkinson disease.